Serif Health vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Healthcare price transparency API and data infrastructure for CMS compliance; $1.2M monthly revenue at 8 people from YC W21 normalizing hospital and insurer rate files for health plans and employers.
About
Serif Health is a Los Angeles-based healthcare price transparency infrastructure company providing APIs and data products that power hospital rate search, insurance network intelligence, and CMS compliance analytics — helping health plans, self-funded employers, TPAs (third-party administrators), and data analytics firms navigate the complex requirements of the CMS Price Transparency and Transparency in Coverage rules that mandate hospitals and insurers to publish machine-readable pricing files. Founded in 2020 and a Y Combinator W21 graduate, Serif raised $2.52 million from 1984 Ventures and angel investors, achieving $1.2 million in monthly revenue as of December 2024 with an 8-person team.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.